Zobrazeno 1 - 10
of 6 565
pro vyhledávání: ''
Publikováno v:
BMJ Quality & Safety. 31:340-352
BackgroundAlthough little is known about why opioid prescribing practices differ between physicians, clinical competence, specialty training and country of origin may play a role. We hypothesised that physicians with stronger clinical competence and
Autor:
James T Harnett, David M. Wood, Laura Hunter, Alison M. Dines, John R. H. Archer, Shaun L Greene, Paul I. Dargan
Publikováno v:
Emergency Medicine Journal. 39:463-466
BackgroundMethamphetamine is a stimulant drug of abuse with increasing prevalence of use worldwide leading to public health concern. While previous research by our group a decade ago found no evidence of increasing harms associated with methamphetami
Publikováno v:
Drug and Therapeutics Bulletin. 59:185-188
The US Food and Drug Administration (FDA) has approved two drugs for ‘hypoactive sexual desire disorder’ in women, flibanserin (Addyi) in 2015 and bremelanotide (Vyleesi) in 2019. In this paper we examine the outcome measures and clinical trial d
Autor:
J Garg, Analia Alvarez, Elizabeth Zuta-Santillan, Paul Brunetta, Ana Malvar, Cary M. Looney, Brad H. Rovin, Thomas Schindler, Richard Furie, Matthew D Cascino, Imran Hassan, Gustavo Aroca, Hilda Fragoso-Loyo
Publikováno v:
Annals of the Rheumatic Diseases
ObjectiveRandomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II anti-CD20 monoclonal antibody that induces potent B-cell d
Autor:
Gertjan Wolbink, Radboud J E M Dolhain, Hieronymus T W Smeele, Erik Kemper, Theo Rispens, Ineke Hubertina Crijns, Nafise Ghalandari
Publikováno v:
Annals of the Rheumatic Diseases, 81(3), 402-405. BMJ Publishing Group
Annals of the rheumatic diseases, 81(3), 402-405. BMJ Publishing Group
Ghalandari, N, Kemper, E, Crijns, I H, Wolbink, G, Rispens, T, Smeele, H T & Dolhain, R J 2022, ' Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy ', Annals of the Rheumatic Diseases, vol. 81, no. 3, pp. 402-405 . https://doi.org/10.1136/annrheumdis-2021-221036
Annals of the rheumatic diseases, 81(3), 402-405. BMJ Publishing Group
Ghalandari, N, Kemper, E, Crijns, I H, Wolbink, G, Rispens, T, Smeele, H T & Dolhain, R J 2022, ' Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy ', Annals of the Rheumatic Diseases, vol. 81, no. 3, pp. 402-405 . https://doi.org/10.1136/annrheumdis-2021-221036
Background: Increasing evidence suggests that TNF inhibitors (TNFi) are safe to use during pregnancy1. A drawback of TNFi use during pregnancy is active transport across the placenta, which is affected by the structure of the TNFi1. The European Leag
Autor:
Anja Strangfeld, Ana M. Rodrigues, Loreto Carmona, Ludovic Trefond, Charalampos Papagoras, Laure Gossec, N Roux, Kimme L. Hyrich, Saskia Lawson-Tovey, Bernd Raffeiner, Elsa F Mateus, Gözde Kübra Yardımcı, Pedro Machado, Xavier Mariette
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩
Lawson-Tovey, S, Hyrich, K L, Gossec, L, Strangfeld, A, Carmona, L, Raffeiner, B, Yardımcı, G K, Trefond, L, Roux, N, Rodrigues, A, Papagoras, C, Mateus, E F, Mariette, X & Machado, P M 2021, ' SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases ', Annals of the rheumatic diseases . https://doi.org/10.1136/annrheumdis-2021-221217
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩
Annals of the Rheumatic Diseases, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩
Lawson-Tovey, S, Hyrich, K L, Gossec, L, Strangfeld, A, Carmona, L, Raffeiner, B, Yardımcı, G K, Trefond, L, Roux, N, Rodrigues, A, Papagoras, C, Mateus, E F, Mariette, X & Machado, P M 2021, ' SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases ', Annals of the rheumatic diseases . https://doi.org/10.1136/annrheumdis-2021-221217
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩
Patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) are often treated with immunomodulatory or immunosuppressive medications; consequently, they have been excluded alongside other immunocompromised patients from late stages of S
Autor:
Yuri Gorelik, Sigal Pressman, S Greenfeld, Nathan Lederman, Chagit Friss, Naama Geva-Zatorsky, Yechezkel Kashi, Yehuda Chowers, Alexandera Blatt, Revital Kariv, Shay Freilich, G Focht, Shiran Gerassy-Vainberg, Yiska Loewenberg Weisband, Shai S. Shen-Orr, Iris Dotan
Publikováno v:
Gut
ObjectiveAnti-drug antibodies (ADA) to anti-tumour necrosis factor (anti-TNF) therapy drive treatment loss of response. An association between intestinal microbial composition and response to anti-TNF therapy was noted. We therefore aimed to assess t
Autor:
Mi Sun Oh, Jun Lee, Dong-Eog Kim, Ki-Hyun Cho, Sung Il Sohn, Beom Joon Kim, Shina Kim, Wook-Joo Kim, Byung-Chul Lee, Kang Ho Choi, Jee Hyun Kwon, Sang-Soon Park, Jeong-Ho Hong, Tai Hwan Park, Kyusik Kang, Jay Chol Choi, Wi Sun Ryu, Jae Kwan Cha, Yong-Jin Cho, Dae-Hyun Kim, Soo Joo Lee, Hee-Joon Bae, Kyung Bok Lee, Dong Ick Shin, Jong-Moo Park, Man Seok Park, Hong Kyun Park, Joon-Tae Kim, Juneyoung Lee, Ji Sung Lee, Jae Guk Kim, Keun-Sik Hong, Kyung Ho Yu
Publikováno v:
Stroke and Vascular Neurology, Vol, Iss
BackgroundNo study has thoroughly compared the effectiveness of combined antiplatelet treatments (other than clopidogrel–aspirin) versus clopidogrel–aspirin or aspirin alone for early secondary prevention in acute ischaemic stroke.MethodsWe ident
Autor:
María Laura Acosta Felquer, Luciano LoGiudice, Enrique R. Soriano, María Laura Galimberti, Luis Daniel Mazzuoccolo, Javier Rosa
Publikováno v:
Annals of the Rheumatic Diseases. 81:74-79
ObjectivesTo compare the incidence of psoriatic arthritis (PsA) in patients with psoriasis (PsO) according to different treatments for their skin: topics/no treatment, conventional disease-modifying antirheumatic drugs (DMARDs) (cDMARDs) or biologica
Publikováno v:
International Journal of Gynecologic Cancer. 31:1165-1174
The incidence and mortality rates from endometrial cancer continue to increase worldwide, while rates in most other cancers have either plateaued or declined considerably. Uterine serous carcinoma represents a fraction of all endometrial malignancies